DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr | ₹-1,091 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-799 Cr |
Mar2023 | ₹-797 Cr |
Mar2022 | ₹-532 Cr |
Mar2021 | ₹-35 Cr |
Mar2020 | ₹-1,091 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-799 Cr | Negative | |
Mar2023 | ₹-797 Cr | Negative | |
Mar2022 | ₹-532 Cr | Negative | |
Mar2021 | ₹-35 Cr | Negative | |
Mar2020 | ₹-1,091 Cr | - |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹154,935.2 Cr | -2.2% | 0.3% | 58.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,259.0 Cr | 0.5% | -3.4% | 13.4% | Stock Analytics | |
CIPLA | ₹119,705.0 Cr | 2.2% | 3.9% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,953.9 Cr | -1.5% | -7% | -5% | Stock Analytics | |
MANKIND PHARMA | ₹98,468.0 Cr | -1.4% | -6.9% | 5.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,889.3 Cr | -2.3% | -7.4% | 3.7% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.2% |
0.3% |
58.8% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses